ZA927792B - Anti-alpha6-integrin-antibodies. - Google Patents

Anti-alpha6-integrin-antibodies.

Info

Publication number
ZA927792B
ZA927792B ZA927792A ZA927792A ZA927792B ZA 927792 B ZA927792 B ZA 927792B ZA 927792 A ZA927792 A ZA 927792A ZA 927792 A ZA927792 A ZA 927792A ZA 927792 B ZA927792 B ZA 927792B
Authority
ZA
South Africa
Prior art keywords
alpha6
integrin
antibodies
Prior art date
Application number
ZA927792A
Other languages
English (en)
Inventor
Beat Albert Imhof
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA927792B publication Critical patent/ZA927792B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA927792A 1991-10-18 1992-10-09 Anti-alpha6-integrin-antibodies. ZA927792B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91810807 1991-10-18

Publications (1)

Publication Number Publication Date
ZA927792B true ZA927792B (en) 1993-04-20

Family

ID=8208889

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA927792A ZA927792B (en) 1991-10-18 1992-10-09 Anti-alpha6-integrin-antibodies.

Country Status (8)

Country Link
US (1) US5538725A (xx)
EP (1) EP0537654A3 (xx)
JP (1) JPH05308994A (xx)
CN (1) CN1072687A (xx)
AU (1) AU665783B2 (xx)
CA (1) CA2078817A1 (xx)
NZ (1) NZ244696A (xx)
ZA (1) ZA927792B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994015958A2 (en) * 1993-01-08 1994-07-21 Tanabe Seiyaku Co., Ltd. Peptide inhibitors of cell adhesion
WO2000038715A2 (en) 1998-12-23 2000-07-06 G.D. Searle & Co. Use of an integrin antagonist and radiation in the treatment of neoplasia
JP2003500023A (ja) * 1999-04-30 2003-01-07 バイオストラタム インコーポレイテッド ラミニン８及びその使用方法
SE9903895D0 (sv) 1999-10-28 1999-10-28 Active Biotech Ab Novel compounds
WO2001080872A1 (en) * 2000-04-21 2001-11-01 George Washington University Method of binding integrin for treatment of cancer
WO2001089552A1 (en) * 2000-05-23 2001-11-29 Histatek, Llc Modulaton of alpha-6 integrin-mediated responses
US20050069549A1 (en) 2002-01-14 2005-03-31 William Herman Targeted ligands
WO2003079974A2 (en) * 2002-03-18 2003-10-02 The Arizona Board Of Regents On Behalf Of The University Of Arizona Integrin ligand
US20050220760A1 (en) * 2004-04-02 2005-10-06 Clemson University Novel immunotherapy
CN102333543B (zh) * 2009-02-24 2014-05-14 国立大学法人宫崎大学 细胞粘附抑制剂及其用途
US20150218213A1 (en) * 2012-09-04 2015-08-06 Università Degli Studi Di Torino Inhibitors of alpha6 integrin/e-cadherin complex
EP2703005A1 (en) * 2012-09-04 2014-03-05 Università Degli Studi Di Torino Inhibitors of alpha6 Integrin/E-Cadherin Complex
WO2023133595A2 (en) 2022-01-10 2023-07-13 Sana Biotechnology, Inc. Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses
WO2024081820A1 (en) 2022-10-13 2024-04-18 Sana Biotechnology, Inc. Viral particles targeting hematopoietic stem cells
WO2024119157A1 (en) 2022-12-02 2024-06-06 Sana Biotechnology, Inc. Lipid particles with cofusogens and methods of producing and using the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ239834A (en) * 1990-09-24 1992-11-25 Becton Dickinson Co Polypeptide and protein complex of gp98 cell surface glycoprotein; monoclonal antibody against it and their use

Also Published As

Publication number Publication date
EP0537654A3 (en) 1993-12-29
EP0537654A2 (en) 1993-04-21
US5538725A (en) 1996-07-23
CA2078817A1 (en) 1993-04-19
CN1072687A (zh) 1993-06-02
AU2636292A (en) 1993-04-22
NZ244696A (en) 1994-10-26
AU665783B2 (en) 1996-01-18
JPH05308994A (ja) 1993-11-22

Similar Documents

Publication Publication Date Title
DE69107059D1 (en) Sigma-delta-modulator.
ZA92908B (en) Compounds.
EP0597463A3 (en) Thermotherapiesonde.
AR244753A1 (es) Azocolorantes.
EP0580285A3 (en) Auto-reclosers.
DE69112211D1 (en) Luftreinigungsvorrichtung.
DE69111595D1 (en) Squarylium- und crokonyliumfarbstoffe.
DE69104185D1 (en) Luftreservoir.
ZA929517B (en) Compounds.
DE59204008D1 (en) Trachealstent.
ZA926482B (en) Cyanophenylpyrroles.
DE69106281D1 (en) Phenanthrenderivat.
EP0572808A3 (de) Antiblockierregelsystem.
ZA927792B (en) Anti-alpha6-integrin-antibodies.
EP0668864A4 (en) SUBSTITUTED BIPHENYLMETHYLIMIDAZOPYRIDINES.
ZA929590B (en) Diphenylsulphides.
DE69102644D1 (en) Demodulationsreferenzsignalquelle.
OA09716A (en) Benzoxaiole derivatives.
EP0576606A4 (en) RESIDUAL PROTEASE-III.
DE69110012D1 (en) Linienerkennungsverfahren.
DE69114491D1 (en) Olefincopolymere.
EP0599191A3 (en) Engine speed control circuit.
ZA929724B (en) Ballisitc materials.
DE69205795D1 (en) Mesoprotheseunterlage.
EP0572573A4 (en) Thyroid-derived chondrocyte-stimulating factor.